SIGA Technologies, Inc. (SIGA)
NasdaqGM · USD · Healthcare · Drug Manufacturers - Specialty & Generic
$3.16 (+1.12%) as of
Key statistics
- Market cap
- 226.69M
- Forward P/E
- 2.92
- EPS (TTM)
- -0.0400
- Dividend yield
- 0.00%
- 52-week range
- 2.8300 – 8.5400
- Beta
- 0.96
- Revenue (TTM)
- 53.66M
- Profit margin
- -5.19%
- Volume
- 378.66k
About SIGA Technologies, Inc.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- New York, NY, United States
- Employees
- 49
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.